• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1550400-18
Device Problems Material Rupture (1546); Difficult or Delayed Activation (2577)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/24/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Concomitant medical products: guide wire: sion blue, guide catheter: 6fr spb 3.5.The device was received.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the emergent procedure was performed to treat a concentric lesion in the distal left circumflex coronary artery with no tortuosity, no calcification and 90% stenosis in a patient with acute coronary syndrome.A 4.00 x 18 mm xience sierra stent delivery system (sds) was advanced to the lesion with no resistance.On attempting to inflate the balloon to deploy the stent of the sds, the pressure gauge of the unspecified indeflator did not move.Continued pressure was applied and the gauge reached 10 atmospheres; however, the pressure was not maintained.The stent was deployed at the target lesion and the sds was removed without issue.Outside of the anatomy, a balloon rupture of the sds was noted.Intravascular ultrasound noted that the stent was dilated unevenly with the proximal portion at 2.0 mm in diameter compared to 4.0 mm in diameter distally.An unspecified non-complaint balloon catheter was used successfully to complete the procedure.There was no adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Internal file number: (b)(4).Evaluation summary: the device was returned for analysis.The reported material rupture was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined the reported material rupture and difficulty to deploy appears to be related to a potential product quality issue.The issue is being addressed per internal operating procedures.Abbott vascular will continue to trend the performance of these devices.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8437718
MDR Text Key139365302
Report Number2024168-2019-02183
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 04/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/11/2021
Device Catalogue Number1550400-18
Device Lot Number8032641
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer03/08/2019
Initial Date Manufacturer Received 02/24/2019
Initial Date FDA Received03/20/2019
Supplement Dates Manufacturer Received04/11/2019
Supplement Dates FDA Received04/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-